Needle-Free patch could protect against bird flu
NCT ID NCT06417853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new vaccine for H7N9 bird flu, given through a small patch with tiny needles instead of a shot. Researchers wanted to see if it was safe and how the body reacted. The trial involved 267 healthy adults aged 18 to 50, who received two doses of the vaccine either by patch or injection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Influenza A (H7N9) vaccine
- What this could lead to
- If successful, this could lead to a needle-free, easy-to-use vaccine for H7N9 bird flu, helping to protect against a potential pandemic.
- What could go wrong
- This is an early phase 1 trial focused on safety, not effectiveness. The vaccine may not trigger a strong immune response or could cause unexpected side effects. Results may not apply to older adults or those with health conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for H7N9 INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doherty Clinical Trials Ltd
East Melbourne, Victoria, 3002, Australia
-
University of Sunshine Coast Clinical Trials
Morayfield, Queensland, 4506, Australia
-
University of Sunshine Coast Clinical Trials
Sippy Downs, Queensland, 4556, Australia
-
University of Sunshine Coast Clinical Trials
South Brisbane, Queensland, 4101, Australia